GeekWire Logo
Menu
  • Home
  • News
    • Amazon
    • Artificial Intelligence
    • Civic
    • Geek Life
    • Health/Life Sciences
    • Microsoft
    • GeekWire Podcast
    • Space
    • Startups sponsored by Google for Startups
    • Positive Charge Podcast sponsored by Amazon Sustainability
    • Sustainability sponsored by Amazon Sustainability
    • Tech Moves presented by GeekWork Recruiting
    • Agents of Transformation presented by Accenture
  • GeekWork
    • GeekWork Recruiting
    • Job Board
  • Events
    • Community Calendar
    • GeekWire Events
  • Lists
    • GeekWire 200
    • GeekWire Startup List presented by ALLtech
    • GeekWire Startup Resources
    • GeekWire Startup Spaces
    • Layoff Tracker
    • M&As and IPOs
    • Northwest Women VC & Angel Investor List
    • Recent Fundings
    • Seattle Engineering Outposts
    • Venture Capital Directory
  • Members
    • Health Benefits
    • Memberships
  • Studios
    • GeekWire Studios: Let Us Tell Your Story
    • Nasdaq Milestone Summit 2026
    • Does Compute presented by Carnegie Mellon University
    • AI Agents and Tools Podcast Series presented by AWS Marketplace
    • F5 30th Anniversary
    • AI Breakthrough Awards presented by UiPath
    • AI Innovators Spotlight Studio 2026 presented by AWS Marketplace
    • Nebius at NVIDIA GTC 2026
    • Acumatica Summit 2026
    • BMC Control Freaks Unite presented by BMC
    • AI Predictions Series 2026 presented by Unify Consulting
    • Guide to re:Invent 2025 sponsored by AWS
    • Remitly Reimagine 2025 sponsored by Remitly
    • AWS Marketplace Seller Conference 2025 sponsored by AWS
    • ShopTalk 2025 powered by Amazon Ads
  • About
    • About GeekWire
    • Advertise
    • Contact Us
    • Email Newsletters
    • Reprints & Permissions
  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips

What happens here matters everywhere.

  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips
  • Amazon
  • Microsoft
  • Startups
  • AI
  • Science
  • Tech Moves
  • Sustainability
  • Civic
  • Geek Life

Biotech

Univ. of Wash.-spinout Icosavax raises $100M to fund vaccine development technology

New funding: At a moment when vaccines are on everyone’s mind, a Seattle-based biotech company that has an unusual approach… Read More

Seattle biotech startup Outpace Bio raises $30M to fight cancer with custom-designed proteins

New funding: Outpace Bio raised a $30 million Series A investment round to design custom cell and gene-based therapies. The… Read More

Led by former Juno and Alder exec, Seattle neurology startup Eliem Therapeutics raises $80M

New funding: Eliem Therapeutics, a new Seattle biotech startup led by former Juno Therapeutics exec Bob Azelby, raised $80 million… Read More

Biotech startup AbSci raises $125M for ‘Protein Printing’ tech; total funding up to $230M

New funding: Vancouver, Wash.-based biotech company AbSci raised $125 million in a round led by Casdin Capital and Redmile Group. The… Read More

Presage Biosciences raises $13M and inks new deal with Merck for cancer drug tests

New funds, new partners: Seattle’s Presage Biosciences announced $13 million in funding as well new collaborations with biotech giant Merck… Read More

Notch Therapeutics raises $85M for cancer treatments and plans to open Seattle location

New funding: Notch Therapeutics has raised a $85 million Series A round, bringing its total funding to $91 million. The… Read More

Fred Hutch biotech spinout Ozette raises $6M from Madrona, AI2, Vulcan

New funding: Ozette, a biotech company that last year spun out of the Fred Hutchinson Cancer Research Center and was… Read More

Sana Biotechnology files to go public, looks to cure disease by modifying genes in the body

Less than three years after it was founded and with no revenue on the books, Sana Biotechnology filed to go… Read More

UW spinout Opticyte lands $4.6M to test device that quickly detects early signs of organ failure

University of Washington biotech spinout Opticyte has landed $2.9 million in federal grants and $1.7 million in seed funding. The… Read More

Well-funded stealthy biotech startup Nautilus hires former Smartsheet, Isilon, GenapSys execs

Sujal Patel is getting the band back together at his secretive new biotech startup Nautilus Biotechnology. The company is beefing… Read More

Silverback Therapeutics prices IPO at $21/share, will raise $241M in 4th Wash. state IPO of 2020

Silverback Therapeutics will raise $241.5 million as the Seattle biotech company goes public Friday. Silverback priced its IPO on Thursday… Read More

Washington State U. launches ‘Spinout Space in Spokane’ incubator for life sciences startups

Washington State University is launching a new life sciences incubator in Spokane, Wash., designed to help startups grow out of… Read More

Seattle biotech firm Umoja Biopharma raises $53M as it tackles unique approach to immunotherapy

Umoja Biopharma raised $53 million to expand development of its CAR T-cell immunotherapy treatments for blood-based and organ-based tumors in… Read More

Seattle Children’s Therapeutics leverages biotech innovation in quest for new treatments for kids

Can a nonprofit research institution operate more effectively by taking a page from the commercial biotech industry? That’s the idea… Read More

Seattle biotech Silverback Therapeutics raises $85M, just six months after raising $78.5M

Seattle biotech startup Silverback Therapeutics continues to raise capital to support development of its therapies for cancer, fibrosis, and other conditions.… Read More

Athira Pharma prices IPO at $17/share, will raise $204M in third Washington state IPO of 2020

Athira Pharma will raise at least $204 million as the Seattle biotech startup becomes a public company on Friday. Athira… Read More

Bill Gates and Jeff Bezos-backed cancer detection company Grail, led by ex-Juno CEO, files for IPO

Cancer detection startup Grail today filed to go public as the Silicon Valley biotech aims to raise more funding for… Read More

Seattle’s Athira Pharma files for IPO to fund quest for Alzheimer’s and Parkinson’s breakthroughs

Athira Pharma is aiming to go public. The Seattle biotech filed initial IPO paperwork Wednesday, a surprising move that would… Read More

Researcher with Seattle ties awarded $4.2M to develop DNA vaccine against COVID-19

A researcher with ties to Seattle-based biotech company OncoSenX has received a $4.2 million grant from the Canadian Institutes of… Read More

Chinook Therapeutics to merge with Aduro Biotech as it pushes forward with kidney disease therapies

Chinook Therapeutics, a biotech company creating targeted therapies for kidney diseases, has agreed to merge with Berkeley, Calif.-based Aduro Biotech.… Read More

Seattle biotech startup Athira raises $85M to develop therapies for Alzheimer’s and Parkinson’s

The foundation of Athira Pharma began while Leen Kawas was earning her Ph.D. in molecular pharmacology at Washington State University nearly… Read More

A-Alpha Bio scientist Emily Engelhart

A-Alpha Bio wins $620,000 grant to work on ‘molecular glue’ for treating disease

A-Alpha Bio, a Seattle venture that began at the University of Washington, has won a $620,472 grant from the National… Read More

Good Therapeutics raises $11M to develop ‘context dependent’ protein drugs

Seattle biotech startup Good Therapeutics raised another $11 million to create “context dependent” protein drugs that act only when needed.… Read More

Seattle biotech startup OncoSenX raising more cash for cancer-fighting therapies

Biotech startup OncoSenX is raising more cash to help support its pipeline of therapeutics that aim to kill cancer cells… Read More

Microsoft and Adaptive Biotechnologies partner to study immune response to COVID-19

Microsoft and Seattle-based Adaptive Biotechnologies announced Friday they will work together to map the immune response to COVID-19. The goal… Read More

Seattle biotech startup Silverback Therapeutics raises $78.5M

Seattle biotech startup Silverback Therapeutics raised a $78.5 million investment round to support development of its therapies for cancer, fibrosis,… Read More

Seattle Genetics stock jumps 17% on breast cancer drug trial success

Shares of cancer drug maker Seattle Genetics soared more than 17 percent Monday morning following positive results for a new… Read More

Shares of Gates-backed Vir Bio tumble after $143M IPO to fund infectious disease efforts

It was a rough Wall Street debut for Vir Biotechnology, a San Francisco company with ambitious plans to battle infectious… Read More

Bioeconomy summit

Biotech experts gather at the White House for ‘Summit on America’s Bioeconomy’

More than 100 biotech researchers, industry executives and government officials met at the White House today for a summit focusing… Read More

Stem cell startup Silene Biotech acquired by NanoSurface Biomedical in all-Seattle deal

NanoSurface Biomedical has snapped up Silene Biotech in a union of two Seattle startups that bets on the growing importance… Read More

  • Older
  • Newer

Latest Stories

    Read All Stories

    GeekWire Newsletters

    Subscribe to GeekWire's free newsletters to catch every headline

    Send Us a Tip

    Have a scoop that you'd like GeekWire to cover? Let us know.

    Send Us a Tip

    A Word From Our Sponsors

    About

    • About GeekWire
    • Contact Us
    • Partner With Us
    • Become a GeekWire Member
    • Send Us a Tip
    • Join Our Startup List
    • Reprints and Permissions

    Follow

    • Facebook
    • X
    • LinkedIn
    • Instagram
    • RSS Feed
    • Podcast
    • YouTube
    • Bluesky

    GeekWire Newsletters

    Catch every headline in your inbox

    Read GeekWire

    • Apple News
    • Google News

    Legal

    • Privacy Policy
    • Terms of Use
    • Sponsored Content Policy
    Return to Top of Page
    © 2011-2026 GeekWire, LLC
    Do Not Sell or Share My Personal information
    Limit the Use Of My Sensitive Personal Information
    Consent Preferences

    Don't miss a headline!

    Sign up for GeekWire's newsletters today.

    Thanks for subscribing!
    Check your inbox to confirm your subscription.